| pubmed-article:15956160 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15956160 | lifeskim:mentions | umls-concept:C0175677 | lld:lifeskim |
| pubmed-article:15956160 | lifeskim:mentions | umls-concept:C0040300 | lld:lifeskim |
| pubmed-article:15956160 | lifeskim:mentions | umls-concept:C0751964 | lld:lifeskim |
| pubmed-article:15956160 | lifeskim:mentions | umls-concept:C1546988 | lld:lifeskim |
| pubmed-article:15956160 | lifeskim:mentions | umls-concept:C1517945 | lld:lifeskim |
| pubmed-article:15956160 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15956160 | pubmed:dateCreated | 2005-6-15 | lld:pubmed |
| pubmed-article:15956160 | pubmed:abstractText | There is an increasing body of evidence that magnetic resonance imaging-occult tissue damage is an important component of primary progressive multiple sclerosis (PPMS) pathology. Proton magnetic resonance spectroscopy (1H-MRS) can be used to measure in vivo whole-brain N-acetylaspartate (WBNAA) concentrations, the decrease of whose levels is considered a marker of neuronal-axonal injury. | lld:pubmed |
| pubmed-article:15956160 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15956160 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15956160 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15956160 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15956160 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15956160 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15956160 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15956160 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15956160 | pubmed:issn | 0003-9942 | lld:pubmed |
| pubmed-article:15956160 | pubmed:author | pubmed-author:RossiPaoloP | lld:pubmed |
| pubmed-article:15956160 | pubmed:author | pubmed-author:FilippiMassim... | lld:pubmed |
| pubmed-article:15956160 | pubmed:author | pubmed-author:ComiGiancarlo... | lld:pubmed |
| pubmed-article:15956160 | pubmed:author | pubmed-author:FaliniAndreaA | lld:pubmed |
| pubmed-article:15956160 | pubmed:author | pubmed-author:ScottiGiusepp... | lld:pubmed |
| pubmed-article:15956160 | pubmed:author | pubmed-author:RovarisMarcoM | lld:pubmed |
| pubmed-article:15956160 | pubmed:author | pubmed-author:ComolaMauroM | lld:pubmed |
| pubmed-article:15956160 | pubmed:author | pubmed-author:GalloAntonioA | lld:pubmed |
| pubmed-article:15956160 | pubmed:author | pubmed-author:BenedettiBeat... | lld:pubmed |
| pubmed-article:15956160 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15956160 | pubmed:volume | 62 | lld:pubmed |
| pubmed-article:15956160 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15956160 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15956160 | pubmed:pagination | 898-902 | lld:pubmed |
| pubmed-article:15956160 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:meshHeading | pubmed-meshheading:15956160... | lld:pubmed |
| pubmed-article:15956160 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15956160 | pubmed:articleTitle | Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. | lld:pubmed |
| pubmed-article:15956160 | pubmed:affiliation | Neuroimaging Research Unit, Scientific Institute and University Ospedale San Raffaele, Milan, Italy. | lld:pubmed |
| pubmed-article:15956160 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15956160 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15956160 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15956160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15956160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15956160 | lld:pubmed |
